CUSIP: 128058203
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,897,672
-
Share change
-
+530,462
-
Total reported value
-
$3,411,036
-
Put/Call ratio
-
274%
-
Price per share
-
$1.80
-
Number of holders
-
24
-
Value change
-
+$954,368
-
Number of buys
-
14
-
Number of sells
-
3
Quarterly Holders Quick Answers
What is CUSIP 128058203?
CUSIP 128058203 identifies CLBS - CALADRIUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 128058203:
Institutional Holders of CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) as of Q3 2020
As of 30 Sep 2020,
CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,897,672 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, SABBY MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, CIBC Private Wealth Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and BlackRock Inc..
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.